— Know what they know.
Not Investment Advice

PRPH OTC

ProPhase Labs, Inc.
1W: +43.6% 1M: -21.8% 3M: -78.5% YTD: -95.6% 1Y: -99.7% 3Y: -99.9% 5Y: -99.9%
$0.02
+0.00 (+31.67%)
 
Weekly Expected Move ±35.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 44 · $221456 mcap · 14M float · 1.12% daily turnover · Short 34% of daily vol

Balance Sheet Trends

Total Assets
$63M -31.2% ▼
5Y CAGR: +38.8%
Total Liabilities
$56M +31.3% ▲
5Y CAGR: +121.7%
Shareholders Equity
$7M -85.1% ▼
5Y CAGR: -8.1%
Cash & Investments
$678K -85.7% ▼
5Y CAGR: -13.0%
Total Debt
$25M +33.1% ▲
Net Debt
$24M +41.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$7M$9M$9M$2M$678K
Short-Term Investments$2M$9M$8M$3M$0
Cash & ST Investments$8M$18M$17M$5M$678K
Net Receivables$3M$38M$37M$36M$20M
Inventory$3M$5M$4M$2M$1M
Other Current Assets$1M$1M$2M$5M$9M
Total Current Assets$16M$61M$61M$48M$31M
Property, Plant & Equip.$8M$10M$11M$15M$12M
Goodwill & Intangibles$2M$17M$14M$18M$15M
Long-Term Investments$3M$0$0$0$0
Other Non-Current Assets$2M$1M$1M$5M$6M
Total Non-Current Assets$16M$28M$27M$44M$33M
Total Assets$31M$89M$88M$92M$63M
— Liabilities —
Accounts Payable$4M$7M$6M$9M$14M
Short-Term Debt$329K$663K$301K$3M$7M
Deferred Revenue$169K$2M$2M$2M$2M
Other Current Liabilities$2M$4M$3M$3M$8M
Total Current Liabilities$6M$16M$16M$21M$32M
Long-Term Debt$10M$10M$2M$7M$12M
Other Non-Current Liab.$0$0$0$5M$5M
Total Non-Current Liabilities$15M$15M$8M$22M$24M
Total Liabilities$21M$31M$24M$43M$56M
— Equity —
Common Stock$14K$16K$16K$18K$23K
Retained Earnings-$4M$3M$12M-$5M-$58M
Accumulated OCI-$11K-$175K$757K-$300K-$198K
Total Stockholders Equity$11M$59M$64M$49M$7M
Total Liabilities & Equity$31M$89M$88M$92M$63M
— Key Metrics —
Total Debt$15M$15M$7M$18M$25M
Net Debt$8M$6M-$2M$17M$24M
Total Investments$4M$9M$8M$3M$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms